SE9003523L - Injicerbar loesning och foerfarande foer framstaellning daerav - Google Patents

Injicerbar loesning och foerfarande foer framstaellning daerav

Info

Publication number
SE9003523L
SE9003523L SE9003523A SE9003523A SE9003523L SE 9003523 L SE9003523 L SE 9003523L SE 9003523 A SE9003523 A SE 9003523A SE 9003523 A SE9003523 A SE 9003523A SE 9003523 L SE9003523 L SE 9003523L
Authority
SE
Sweden
Prior art keywords
bis
indole
preparing
procedure
compositions
Prior art date
Application number
SE9003523A
Other languages
Unknown language ( )
English (en)
Other versions
SE509715C2 (sv
SE9003523D0 (sv
Inventor
M Gazdag
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE9003523D0 publication Critical patent/SE9003523D0/sv
Publication of SE9003523L publication Critical patent/SE9003523L/sv
Publication of SE509715C2 publication Critical patent/SE509715C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Press Drives And Press Lines (AREA)
  • Press-Shaping Or Shaping Using Conveyers (AREA)
  • Powder Metallurgy (AREA)
SE9003523A 1989-11-07 1990-11-06 Injicerbar lösning och förfarande för framställning av densamma SE509715C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (3)

Publication Number Publication Date
SE9003523D0 SE9003523D0 (sv) 1990-11-06
SE9003523L true SE9003523L (sv) 1991-05-08
SE509715C2 SE509715C2 (sv) 1999-03-01

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003523A SE509715C2 (sv) 1989-11-07 1990-11-06 Injicerbar lösning och förfarande för framställning av densamma

Country Status (37)

Country Link
US (1) US5397784A (sv)
JP (1) JP3042702B2 (sv)
KR (1) KR0164601B1 (sv)
CN (1) CN1053569C (sv)
AR (1) AR245592A1 (sv)
AT (1) AT401469B (sv)
AU (1) AU638504B2 (sv)
BE (1) BE1004051A4 (sv)
BG (1) BG60609B1 (sv)
CA (1) CA2029368C (sv)
CH (1) CH682130A5 (sv)
CZ (1) CZ279433B6 (sv)
DE (1) DE4035253B4 (sv)
DK (1) DK266390A (sv)
ES (1) ES2026062A6 (sv)
FI (1) FI100455B (sv)
FR (1) FR2653998B1 (sv)
GB (1) GB2238241B (sv)
GR (1) GR1001041B (sv)
HU (1) HU204995B (sv)
IE (1) IE62387B1 (sv)
IL (1) IL96249A (sv)
IT (1) IT1242724B (sv)
LT (1) LT3334B (sv)
LV (1) LV10687B (sv)
MY (1) MY104595A (sv)
NL (1) NL9002412A (sv)
NO (1) NO175565C (sv)
NZ (1) NZ236005A (sv)
PL (1) PL164881B1 (sv)
PT (1) PT95810B (sv)
RU (1) RU1828401C (sv)
SE (1) SE509715C2 (sv)
SK (1) SK540290A3 (sv)
UA (1) UA13162A (sv)
YU (1) YU48373B (sv)
ZA (1) ZA908855B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
SE509715C2 (sv) 1999-03-01
AU6584590A (en) 1991-05-16
SK278421B6 (en) 1997-05-07
GB2238241A (en) 1991-05-29
MY104595A (en) 1994-04-30
CZ540290A3 (en) 1994-11-16
UA13162A (uk) 1997-02-28
KR0164601B1 (ko) 1999-01-15
GB9024222D0 (en) 1990-12-19
IT9067868A1 (it) 1992-05-06
HUT55225A (en) 1991-05-28
CA2029368A1 (en) 1991-05-08
IE62387B1 (en) 1995-01-25
CA2029368C (en) 2000-01-04
ATA223090A (de) 1996-02-15
HU204995B (en) 1992-03-30
NO175565C (no) 1994-11-02
LV10687A (lv) 1995-06-20
FR2653998A1 (fr) 1991-05-10
LTIP512A (en) 1994-11-25
FI905508A0 (fi) 1990-11-07
NO904821D0 (no) 1990-11-06
BG93175A (bg) 1993-12-24
AR245592A1 (es) 1994-02-28
GR900100795A (en) 1992-04-17
IL96249A (en) 1995-07-31
LT3334B (en) 1995-07-25
HU895804D0 (en) 1990-01-28
YU209590A (sh) 1993-05-28
SK540290A3 (en) 1997-05-07
SE9003523D0 (sv) 1990-11-06
JP3042702B2 (ja) 2000-05-22
NO175565B (no) 1994-07-25
DE4035253B4 (de) 2004-10-07
FI100455B (sv) 1997-12-15
YU48373B (sh) 1998-07-10
IT9067868A0 (it) 1990-11-06
AT401469B (de) 1996-09-25
DE4035253A1 (de) 1991-05-08
BE1004051A4 (fr) 1992-09-15
PL164881B1 (en) 1994-10-31
JPH03206040A (ja) 1991-09-09
ES2026062A6 (es) 1992-04-01
DK266390D0 (da) 1990-11-06
DK266390A (da) 1991-05-08
GR1001041B (el) 1993-03-31
BG60609B1 (bg) 1995-10-31
KR910009245A (ko) 1991-06-28
US5397784A (en) 1995-03-14
IE903993A1 (en) 1991-05-08
LV10687B (en) 1995-12-20
CN1053569C (zh) 2000-06-21
RU1828401C (ru) 1993-07-15
CN1053185A (zh) 1991-07-24
ZA908855B (en) 1991-08-28
IT1242724B (it) 1994-05-17
IL96249A0 (en) 1991-08-16
AU638504B2 (en) 1993-07-01
NL9002412A (nl) 1991-06-03
PT95810A (pt) 1991-09-13
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
GB2238241B (en) 1993-10-06
NO904821L (no) 1991-05-08
CH682130A5 (sv) 1993-07-30
CZ279433B6 (cs) 1995-04-12
FR2653998B1 (fr) 1995-02-17

Similar Documents

Publication Publication Date Title
US3957980A (en) Doxycycline parenteral compositions
ES470407A1 (es) Procedimiento para la preparacion de un compuesto tetraci- clico
NZ213758A (en) Stable, injectable solution of piroxicam
MY105168A (en) Novel compositions containing hyaluronic acid associates and a process for preparing same.
HUT41759A (en) Process for producing new pharmaceutical composition containing ipriflavone in form of cyclodextrine inclusion complex
ES2107659T3 (es) Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares.
HK1075197A1 (en) New composition containing taxane derivatives as major component
SE9003523L (sv) Injicerbar loesning och foerfarande foer framstaellning daerav
US4138565A (en) Stable solutions and processes for their preparation
IL83086A (en) Stable,injectable solutions of vincristine salts
AR012826A1 (es) Complejo de bis-platino (ii), metodo para preparar dicho complejo y uso del mismo en la preparacion de una composicion farmaceutica para tratar tumores.
GB1465783A (en) Pyrrolyl compounds and processes for their manufacture
ES8701185A1 (es) Un procedimiento para preparar un complejo metalico farma- ceuticamente aceptable de un compuesto bis-indolico
CA2556254A1 (en) Aqueous solution preparation containing camptothecins
GB1596948A (en) Stable solutions of hydrogenated ergopeptide alkaloids
GB769517A (en) Analgesic compositions
KR890003788A (ko) 신규한 말로네이트 유도체의 수용성 백금복합체 및 그의 제조방법
GB1180120A (en) Pharmaceutical Compositions Containing Alkaloids.
ES369304A1 (es) Procedimiento de preparacion de nuevos derivados nitrogena-dos de la metil-2 benzil-3 imidazo-3h (4,5-b) piridina.
KR910020018A (ko) 피리도[3, 4-b] 피롤로[1, 2-e][1, 4, 5]옥사디아제핀 및 이의 관련 동족체 이의 제조방법 및 약제로서의 이의 용도
ES293574A1 (es) Procedimiento de preparaciën del glucoheptonato de hierro
KR900004713A (ko) 디아민 유도체 및 그의 제조방법
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
GB1394195A (en) Benzodiazepine derivatives and the production thereof
GB1282076A (en) N-vinyl-quinolones

Legal Events

Date Code Title Description
NUG Patent has lapsed